ELIXINOL WELLNESS LIMITED (EXL)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
EXL - ELIXINOL WELLNESS LIMITED
FNArena Sector :
Health & Nutrition
Year End: December
GICS Industry Group : Household & Personal Products
Debt/EBITDA: -0.22
Index:
FNArena Sector : Health & Nutrition
Year End: December
GICS Industry Group : Household & Personal Products
Debt/EBITDA: -0.22
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.005
20 Nov |
0.000 OPEN $0.01 |
0.000 HIGH $0.01 |
16,942,535 LOW $0.01 |
| OTHER COMPANIES IN THE SAME SECTOR | |||
| CLV . EBO . MCP . SIG . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | -1.2 |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 8.3 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 0.8 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -2.8 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -90.78 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -96.12 % |
| Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -90.28 % |
| Return on Assets | xxx | xxx | xxx | xxx | xxx | -59.59 % |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | -96.12 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -68.74 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -2.8 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 1 M |
| Long Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
| Total Debt | xxx | xxx | xxx | xxx | xxx | 1 M |
| Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
| Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 1 M |
| Price To Book Value | xxx | xxx | xxx | xxx | xxx | 1.18 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capex | xxx | xxx | xxx | xxx | xxx | 0.0 M |
| Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 0.21 % |
| Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 10 M |
| Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 5 M |
| Research & Development | xxx | xxx | xxx | xxx | xxx | - |
| Investments - Total | xxx | xxx | xxx | xxx | xxx | 0 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
EXL STOCK CHART
FNArena News on EXL
| 1 |
Spotlight On ASX-Listed Cannabis CompaniesJan 31 2024 - Small Caps |
| 2 |
Rudi’s View: All Eyes On November 3Sep 24 2020 - Rudi's View |
| 3 |
Australian Broker Call *Extra* Edition – July 1, 2020Jul 01 2020 - Daily Market Reports |
| 4 |
Australian Broker Call *Extra* Edition – Apr 06, 2020Apr 06 2020 - Daily Market Reports |
| 5 |
Australian Broker Call *Extra* Edition – Feb 17, 2020Feb 17 2020 - Daily Market Reports |
Latest Health & Nutrition News
| 1 |
Sigma Healthcare Promises Higher MarginsOct 03 2023 - Small Caps |
| 2 |
Sigma’s Win Not Neccessarily Ebos’ LossJun 14 2023 - Small Caps |
| 3 |
Sigma Healthcare: Brokers WaryMar 31 2022 - Australia |
| 4 |
Health & Wellness Boom On The ASXApr 29 2021 - Weekly Reports |
| 5 |
M&A Now On Sigma Healthcare’s AgendaMar 24 2021 - Australia |
| 6 |
McPherson’s Expands Into Herbal HealthNov 04 2020 - Small Caps |
| 7 |
Nine Ignored Companies Now Worth A LookSep 23 2020 - FYI |
| 8 |
Next Week At A Glance – 14-18 Sep 2020Sep 11 2020 - Weekly Reports |
| 9 |
Sigma Farewells API, Heralds New ContractDec 17 2019 - Australia |
| 10 |
Blackmores: Hopes Pinned On RestructuringNov 01 2019 - Australia |